Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | ||
| Net Income | -24,495 | -30,536 |
| Depreciation Amortization | 1,230 | 4,226 |
| Accounts receivable | -12,068 | -6,662 |
| Other Working Capital | -7,776 | -18,580 |
| Other Operating Activity | 15,312 | 8,771 |
| Operating Cash Flow | $-27,797 | $-42,781 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -345 | -62 |
| Purchase Of Investment | -5,192 | -8,775 |
| Purchase Sale Intangibles | -1,839 | -328 |
| Other Investing Activity | -1,739 | -606 |
| Investing Cash Flow | $-7,276 | $-9,443 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 217 | 57 |
| Other Financing Activity | 61,501 | 34,240 |
| Financing Cash Flow | $61,718 | $34,297 |
| Beginning Cash Position | 7,731 | 25,658 |
| End Cash Position | 34,376 | 7,731 |
| Net Cash Flow | $26,645 | $-17,927 |
| Free Cash Flow | ||
| Operating Cash Flow | -27,797 | -42,781 |
| Capital Expenditure | -345 | -62 |
| Free Cash Flow | -28,142 | -42,843 |